Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study

OBJECTIVE: HER-MES was the first head-to-head, phase 4 trial to assess the tolerability and effectiveness of erenumab against standard of care treatment (topiramate). This post hoc analysis compared the efficacy of erenumab with topiramate in patients who completed the trial on study medication. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrlich, Marc, Hentschke, Christian, Sieder, Christian, Maier-Peuschel, Monika, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664641/
https://www.ncbi.nlm.nih.gov/pubmed/36380284
http://dx.doi.org/10.1186/s10194-022-01511-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664641/
https://www.ncbi.nlm.nih.gov/pubmed/36380284
http://dx.doi.org/10.1186/s10194-022-01511-y

Ejemplares similares